Search

Search Constraints

You searched for: Author/Creator Fowler, Christopher J.

Search Results

21. Inside Cover: A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis (Angew. Chem. Int. Ed. 50/2014). Issue 50 (22nd October 2014)

23. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors. (1st January 2017)

24. Neurofilament light chain in psychiatric and neurodegenerative disorders: A 'c‐reactive protein' for the brain?: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers. (7th December 2020)

26. Plasma Aβ biomarker associated with cognitive decline in preclinical Alzheimer's disease: Neuropsychology/Neuropsychological correlates of physiologic markers of cognitive decline/Dementia. (7th December 2020)

27. Plasma levels of the endocannabinoid anandamide, related N-acylethanolamines and linoleic acid-derived oxylipins in patients with migraine. (May 2017)

28. Plasma p217+tau concordance with 18F‐NAV4694 beta‐amyloid and 18F‐MK6240 tau PET in mild Alzheimer's disease and cognitively unimpaired participants in the AIBL/ADNeT cohort. (31st December 2021)

29. Plasma p‐tau181/Aβ1‐42 ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ1‐42 and future cognitive decline. Issue 1 (25th November 2022)

30. Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: A Bayesian network analysis of data from a tissue microarray. Issue 11 (9th June 2014)